JPS56135422A - Reagent and method for diagnosis of pancreatic cancer - Google Patents

Reagent and method for diagnosis of pancreatic cancer

Info

Publication number
JPS56135422A
JPS56135422A JP3959480A JP3959480A JPS56135422A JP S56135422 A JPS56135422 A JP S56135422A JP 3959480 A JP3959480 A JP 3959480A JP 3959480 A JP3959480 A JP 3959480A JP S56135422 A JPS56135422 A JP S56135422A
Authority
JP
Japan
Prior art keywords
pancreatic cancer
poa
pancreatic
diagnosis
fetus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3959480A
Other languages
Japanese (ja)
Inventor
Motoharu Kondo
Toshiichi Yoshikawa
Koichi Nishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanyo Chemical Industries Ltd
Original Assignee
Sanyo Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanyo Chemical Industries Ltd filed Critical Sanyo Chemical Industries Ltd
Priority to JP3959480A priority Critical patent/JPS56135422A/en
Publication of JPS56135422A publication Critical patent/JPS56135422A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE: To carry out the early diagnosis of pancreatic cancer which can hardly be detected at its early stages, easily, by using a pancreatic cancer fetus antigen (POA) labelled with radio-isotope or an enzyme or a POA antibody.
CONSTITUTION: Pancreatic cancer is detected by determining the amount of pancreatic cancer fetus antigen (POA) in the body fluid such as blood serum, pancreatic juice, etc., using a reagent for diagnosis of pancreatic cancer obtained by labelling POA or POA antibody with a ratio-isotope (e.g. 125I, 131I, etc.) or with an enzyme (e.g. peroxidase, β-D-galactosidase, alkali phosphodase, etc.). POA is found to be a specific antigen present exclusively in the fetus pancreatic tissue, pancreatic juice of the pancreatic cancer patient, and pancreatic cancer tissue, and accordingly, the determination of the POA by RIE (radio-immunoassay) or EIA (enzymatic immuno-assay) enables the easy and accurate diagnosis of pancreatic cancer.
COPYRIGHT: (C)1981,JPO&Japio
JP3959480A 1980-03-26 1980-03-26 Reagent and method for diagnosis of pancreatic cancer Pending JPS56135422A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3959480A JPS56135422A (en) 1980-03-26 1980-03-26 Reagent and method for diagnosis of pancreatic cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3959480A JPS56135422A (en) 1980-03-26 1980-03-26 Reagent and method for diagnosis of pancreatic cancer

Publications (1)

Publication Number Publication Date
JPS56135422A true JPS56135422A (en) 1981-10-22

Family

ID=12557427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3959480A Pending JPS56135422A (en) 1980-03-26 1980-03-26 Reagent and method for diagnosis of pancreatic cancer

Country Status (1)

Country Link
JP (1) JPS56135422A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571146A1 (en) * 1984-10-01 1986-04-04 Centre Nat Rech Scient CARCINO-FETAL ANTIGENS OF HUMAN PANCREAS AND A PURIFICATION PROCESS, ANTISERUM AGAINST SUCH ANTIGENS AND ITS PREPARATION METHOD AND DIAGNOSTIC COMPOSITIONS CONTAINING THEM
US4696905A (en) * 1983-05-13 1987-09-29 Special Reference Laboratories, Inc. Method for diagnosing cancer using ESR
JPS62188982U (en) * 1986-05-19 1987-12-01

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
.THE.LANCET.FEBURARY.2.=1980 *
CANCER RES=1978 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696905A (en) * 1983-05-13 1987-09-29 Special Reference Laboratories, Inc. Method for diagnosing cancer using ESR
FR2571146A1 (en) * 1984-10-01 1986-04-04 Centre Nat Rech Scient CARCINO-FETAL ANTIGENS OF HUMAN PANCREAS AND A PURIFICATION PROCESS, ANTISERUM AGAINST SUCH ANTIGENS AND ITS PREPARATION METHOD AND DIAGNOSTIC COMPOSITIONS CONTAINING THEM
WO1986002081A1 (en) * 1984-10-01 1986-04-10 Centre National De La Recherche Scientifique (Cnrs Acino-foetal differentiation proteins associated to the pancreas cancer, antiserum and monoclonal antibodies to said proteins, preparation methods
JPS62500304A (en) * 1984-10-01 1987-02-05 サントル　ナシヨナル　ドウ　ラ　レシエルシエ　スヤンテイフイ−ク（セ−　エヌ　エ−ル　エス） Hydatidiform mole differentiation proteins associated with pancreatic cancer, antisera and monoclonal antibodies against these proteins, and production methods
JPS62188982U (en) * 1986-05-19 1987-12-01

Similar Documents

Publication Publication Date Title
LV10538A (en) Influence of immunologically binding agent on biological fluid and diagnostic agent
CY1115366T1 (en) VOLUME INDICATORS
ES2009939A6 (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans.
JPS57146599A (en) Test composition, test kit and test method for measuring glucose in liquid test sample
GB2106646B (en) Method of ovulation detection and indicator strip for use therein
Liebman Isolation and characterization of a hepatoma-associated abnormal (des-γ-carboxy) prothrombin
DK156668C (en) PROCEDURE FOR QUANTITATIVE DETERMINATION OF BLOOD COAGULATION FACTOR XII IN HUMAN PLASMA
EP0232179A3 (en) Assay for human breast cancer
GB2020424A (en) Determination of glucose
DE3378414D1 (en) Protein (pp13), process for concentrating and obtaining it, and its use
JPS56135422A (en) Reagent and method for diagnosis of pancreatic cancer
JPS5292773A (en) Automatic analyzer
ES8606947A1 (en) Immunoassay.
ES8308924A1 (en) An immunologically active, marked means, its preparation, and its use in an immunological detection or determination method.
ES8707798A1 (en) Processes for the detection of non-A, non-B hepatitis and a kit for use in the same.
EP0248147A3 (en) Method of determining the presence of cancer cells
ZA872145B (en) Method for the detection of pregnancy disorders
Landon et al. The measurement of enzymes by radioimmunoassay: A review
AU3039589A (en) Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor
NO920624L (en) REAGENT FOR DETERMINATION OF FIBRINOLYTIC ACTIVITY
GB1369582A (en) Specific antiserum and method for radioimmunoassay of human chorionic gonadotropin
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
FR2273280A1 (en) Measurement of antigens and antibodies - in biological fluids by immuno diffusion techniques with antibodies marked with enzymes
JPS57161651A (en) Quantitative determination for somatostatin
ATE15944T1 (en) DIAGNOSTIC PROCEDURES.